IL15 and hepatocellular carcinoma: Notably, constitutive co-expression of IL-15 with a glypican-3 CAR conferred greater intrinsic antitumor activity on human Vδ1+ cells in a hepatocellular carcinoma model—without inducing GvHD—highlighting the broadly beneficial role of IL-15 across innate-like platforms (11, 138).